Researchers at the Los Angeles Biomedical Research Institute (LA BioMed) have spotted a new skin condition among cocaine users and have developed a technology tool called VisualDx to diagnose the condition.
Dr. Noah Craft, a dermatologist at LA BioMed encountered patients with a rare skin condition called cocaine-levamisole toxicity among cocaine users. He traced its link to cocaine adulterated with a levamisole, a deworming medicine for sheep. The resultant skin injuries were ghastly and needed both medical and media attention.
To educate fellow medical professionals who might not have come across this rare condition and to prevent misdiagnosis, Dr Craft incorporated more than 100,000 images of the condition into the diagnostic app VisualDx. This will enable the doctors to recognize the disease through the images.
By introducing this app to diagnostic world, Dr. Craft has bridged the gap between medical discoveries and their awareness to the professionals and the general public. What would otherwise take between 1 to 2 years to get to the journals is now made available at an instant.
Skin specialists and physicians can use VisualDx as an inexpensive tool to diagnose and report levamisole toxicity in their patients. From symptoms to treatment everything has been recorded and can offer a ready reckoner solution to the problem.
VisualDx: A Diagnostic App
VisualDx provides a large repertoire of high quality medical images of the disease. The images are all peer reviewed and help the physicians in quick diagnosis and timely management of the condition. Apart from this particular skin condition, there are many other applications available to diagnose infectious diseases in adults as well as children. As a result today VisualDx is voted as one among the top five medical apps and has also received many awards and acclaims for revolutionizing the field of medicine and diagnostics.